MD2Me - Texting to Promote Chronic Disease Management



Status:Completed
Conditions:Irritable Bowel Syndrome (IBS), Gastrointestinal, Pulmonary, Diabetes
Therapuetic Areas:Endocrinology, Gastroenterology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:14 - 22
Updated:4/21/2016
Start Date:October 2009
End Date:March 2012

Use our guide to learn which trials are right for you!

TAHLC - Texting to Promote Adolescent Health Liaisons and Chronic Disease Management

UCSD researchers are conducting a study aimed to develop and evaluate a chronic disease self
management web and text message based program on health-related self-efficacy and frequency
of adolescent-conducted healthcare interactions. We hypothesize that users of the program
will demonstrate greater gains between baseline and 8 month measures of health related
self-efficacy and adolescent-conducted healthcare interactions as compared to the usual care
comparison group.

The MD2Me study (or also known as TAHLC), sponsored by the National Institutes of Health is
a 2-year randomized controlled trial to develop and test a text message and Internet based
intervention among adolescents and young adults with cystic fibrosis, type 1 diabetes, or
inflammatory bowel disease. Adolescents and young adults have been a difficult population to
engage in healthcare. It is estimated that 1 in 5 adolescents do not get the healthcare they
need. Interventions must address how the healthcare system can engage adolescents with
chronic disease and provide opportunities to discuss health-related matters and improve
disease outcomes.

This study will help fill multiple gaps in the literature by exploring the utility of a push
AND pull SMS texting-based application for chronic disease management among youth. Based on
social cognitive theory, the intervention will use accessible technology to promote disease
management among adolescents with chronic disease as they transition to adult care. The
popularity and usage of SMS already demonstrated by adolescents suggests notable promise for
the SMS-based TAHLC program to promote chronic disease self-management and healthcare
engagement with substantial positive impacts on health among youth with chronic disease.

Inclusion Criteria:

- ages 14 - 22 years

- have cystic fibrosis, type 1 diabetes, or inflammatory bowel disease for at least 6
months

- have access to the internet

- speak English

- has a parent that speaks English or Spanish (if primary participant is under 18)

- willingness to attend assessment visits

Exclusion Criteria:

- pregnant or have children

- have a history of substance abuse or other psychiatric disorder that would impair
compliance with study protocol
We found this trial at
1
site
9500 Gilman Dr
La Jolla, California 92093
(858) 534-2230
The University of California, San Diego UC San Diego is an academic powerhouse and economic...
?
mi
from
La Jolla, CA
Click here to add this to my saved trials